Related Experiment Video

Updated: Aug 7, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Secondary prevention of cardioembolic stroke: oldest and newest promises

F Corea1, M Spinelli, N Tambasco

  • 1Stroke Unit, Department of Neurology, Università Vita Salute IRCCS, S. Raffaele, Milano, Italy. corea.francesco@hsr.it

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|July 13, 2006
PubMed

Insights

Atrial fibrillation (AF) patients face stroke risk from cardioembolism. New strategies include advanced antithrombotics, antiarrhythmics, and mechanical interventions like left atrial appendage occlusion for stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Atrial fibrillation (AF) is the leading cause of cardioembolic stroke.
  • Secondary stroke prevention in AF patients requires multifaceted strategies.
  • Current management balances pharmacological and emerging interventional approaches.

Purpose of the Study:

  • To provide an update on secondary stroke prevention strategies for patients with atrial fibrillation.
  • To review current and novel therapeutic options for reducing cardioembolic risk in AF.
  • To highlight the evolving landscape of AF stroke prevention.

Main Methods:

  • Review of current antithrombotic therapies (e.g., warfarin, direct thrombin inhibitors).
  • Discussion of antiarrhythmic treatments for rate control and rhythm restoration.
  • Exploration of mechanical interventions including left atrial appendage occlusion and carotid artery implants.

Main Results:

  • Novel oral anticoagulants and antiplatelet agents offer alternatives to traditional therapy.
  • Ablation technologies show promise for restoring sinus rhythm in select AF patients.
  • Endovascular procedures and cardiac devices provide new avenues for emboli protection.

Conclusions:

  • The management of stroke risk in AF is evolving with new pharmacological and mechanical options.
  • Future research should focus on comparing the efficacy and safety of these diverse prevention strategies.
  • Personalized approaches integrating drug therapy and interventional procedures will likely define future AF stroke prevention.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...